Volume 3, Issue 4, December 2019, Page: 90-93
Erectile Dysfunction Among Hypertensive Patients in Yaounde, Cameroon
Jerome Boombhi, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon; Cardiology Unit, General Hospital of Yaounde, Yaounde, Cameroon
Njoya Poumie Aoudou, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon
Alain Menanga, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon; Cardiology Unit, General Hospital of Yaounde, Yaounde, Cameroon
Donald Tchapmi, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon
Ba Hamadou, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon; Cardiology Unit, General Hospital of Yaounde, Yaounde, Cameroon
Samuel Kingue, Department of Internal Medicine and Specialties, University of Yaounde I, Yaounde, Cameroon; Cardiology Unit, General Hospital of Yaounde, Yaounde, Cameroon
Received: Oct. 1, 2019;       Accepted: Oct. 28, 2019;       Published: Nov. 5, 2019
DOI: 10.11648/j.ccr.20190304.13      View  12      Downloads  4
Abstract
This study was done to determine the prevalence, associated factors and severity factors of erectile dysfunction, in patients with hypertension in Yaounde. It was a cross sectional descriptive and analytical study that included 170 patients. All the participants were screened for erectile dysfunction using the International Index of Erectile Function 5 (IIEF-5). Results showed that the mean age of our participants was 55 +/- 8 years. The prevalence of erectile dysfunction was 50.6%. Among those affected, the severity was classified as mild (46,5%), moderate (33,7%) and severe (19,8%). After a multivariate analysis, erectile dysfunction remained significantly associated with age (p < 0,001), duration of hypertension of more than 5 years (p=0,001), higher grade of hypertension (p=0,011), diabetes (aOR= 24,56; 95% CI: 3,56 – 83,1; p=0,02), tobacco smoking (aOR= 4,83; 95% CI: 2,70 – 33,2; p=0,016), alcohol intake (aOR= 43,1; 95% CI: 2,53 – 732,7; p=0,009), multiple anti-hypertensive medications (aOR = 3,7; 95% CI: 1,51 – 6,78; p=0,006) and usage of thiazide diuretics (aOR =14,3; 95% CI: 4,32 – 47,3; p < 0,001). The severity of erectile dysfunction was significantly associated with age (p < 0,001), duration of hypertension (p < 0,001), severity of hypertension (p < 0,001), diabetes (p < 0,001), tobacco smoking (p = 0,003), alcohol intake (p = 0,003) and multiple antihypertensive medications (p = 0,001). In conclusion, erectile dysfunction has a high prevalence and severity among Cameroonian hypertensive patients. Age, duration of hypertension, severity of hypertension, diabetes, tobacco smoking, alcohol intake and usage of thiazide diuretics were factors associated with this high prevalence and severity.
Keywords
Erectile Dysfunction, Hypertension, Prevalence, Severity
To cite this article
Jerome Boombhi, Njoya Poumie Aoudou, Alain Menanga, Donald Tchapmi, Ba Hamadou, Samuel Kingue, Erectile Dysfunction Among Hypertensive Patients in Yaounde, Cameroon, Cardiology and Cardiovascular Research. Vol. 3, No. 4, 2019, pp. 90-93. doi: 10.11648/j.ccr.20190304.13
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Ibrahim A, Ali M, Kiernan TJ, Stack AG. Erectile Dysfunction and Ischaemic Heart Disease. Eur Cardiol Rev. 2018 Dec; 13 (2): 98–103.
[2]
Feldman HA, Goldstein I, Hatzichristou DG et al. impotence and its medical and psychological correlates: results of Massachusetts Male Aging Study. J urol. 1994; 151 (1): 54-61.
[3]
Soulemane Pessinaba, Soodougoua B, Machihude P et al. La dysfonction érectile chez l’hypertendu togolais: étude transversale chez 100 patients dans le service de cardiologie du CHU campus de Lomé. Pan African Medical Journal. 2015; 21: 47-54.
[4]
Kearney PM, Whelton M, Reynolds K et al. Global burden of hypertension: analysis of worlwide data. Lancet. 2005; 365: 217–23.
[5]
Kingue S, Ndong Ngoe C, Menanga AP et al. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population-based cross-sectional study. The Journal of Clinical Hypertension. 2015 Oct; 17 (10): 819–24.
[6]
Doumas M et al. Factors affecting the increased prevalence of erectile dysfunction in greek hypertensive compared with normotensive subjects. J Androl. 2006 May–Jun; 27 (3): 469-77.
[7]
Rosen RC, Cappeleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the international Index of Erectile Function (IIEF–5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999; 11 (6): 319–326.
[8]
Buranakitjarsen P, Phoojaroenchanachai M, Sarawich S. Prevalence of erectile dysfunction among treated hypertensives males. J Med Assoc Thai. 2006 Nov; 89 (5): 28-36.
[9]
Fafiolu AS, Adebayo AM, Akande TO et al. Erectile dysfunction among male hypertensive in a tertiary health facility in South-west Nigeria. Glob J Health Sci.2014 Aug 22; 7 (1): 154-60.
[10]
Aranda P, Ruilope L, Calvo C et al. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of spanish national study. Am J Hypertension. 2004; 17: 139–45.
[11]
Javaroni V, Neves MF. Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens. 2012: 627-28.
[12]
Grimm RH, Grandits GA, Prineas RJ et al. Long term effects on sexual fucntion of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women (TOHMS). Hypertension. 1997, 29: 8–14.
[13]
Hanon O, Mounier V, Fauvel JP et al. Troubles de la sexualité chez les hypertendus traités. Arch Mal Cœur. 2002; 95: 673–77.
[14]
Ferrini MG, Gonzalez-Cadavid NF, Rajfer J. Aging related erectile dysfunction—potential mechanism to halt or delay its onset. Transl Androl Urol. 2017 Feb; 6 (1): 20–7.
[15]
Wang X-M, Bai Y-J, Yang Y-B, Li J-H, Tang Y, Han P. Alcohol intake and risk of erectile dysfunction: a dose-response meta-analysis of observational studies. Int J Impot Res. 2018 Nov; 30 (6): 342–51.
[16]
Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, et al. Alcohol consumption and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: Baseline data from the Dogo Study. Alcohol Fayettev N. 2016; 55: 17–22.
Browse journals by subject